MedPath

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Registration Number
NCT00003151
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Brief Summary

RATIONALE: Antibiotics may stop the growth of Helicobacter pylori which may be associated with gastric lymphoma.

PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy in treating patients with low grade gastric lymphoma that has not been previously treated.

Detailed Description

OBJECTIVES: I. Determine the rate of eradication of Helicobacter pylori using omeprazole, colloidal bismuth subcitrate, tetracycline, and metronidazole in patients with low grade gastric lymphoma. II. Determine the macroscopic/endoscopic and microscopic healing/remission rate after eradication of Helicobacter pylori in this patient population. III. Determine the natural history of low grade gastric lymphoma after eradication of Helicobacter pylori.

OUTLINE: This is a nonrandomized, open label, multicenter study. Patients receive oral omeprazole bid on days 1-10, oral bismuth subcitrate and oral tetracycline qid on days 4-10, and oral metronidazole tid on days 4-10. Patients are evaluated at 8 weeks. Patients who experience complete remission and are H. pylori negative proceed to follow up. Patients with complete remission or no change but who are H. pylori positive proceed to a second course of therapy with the previous schedule or with omeprazole bid, amoxicillin qid, and clarithromycin tid for 14 days. Patients who experience no change but are H. pylori negative are followed at 6 and 9 months and restaged. Patients are followed at 6, 9, 12, 18, and 24 months, then annually thereafter.

PROJECTED ACCRUAL: Approximately 60-96 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
96
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (22)

Royal United Hospital

🇬🇧

Bath, England, United Kingdom

University Birmingham N.H.S. Trust

🇬🇧

Birmingham, England, United Kingdom

Royal Free Hospital

🇬🇧

Hampstead, London, England, United Kingdom

St. James's Hospital

🇬🇧

Leeds, England, United Kingdom

Saint Bartholomew's Hospital

🇬🇧

London, England, United Kingdom

Royal Free Hospital School of Medicine

🇬🇧

London, England, United Kingdom

Guy's, King's and St. Thomas' Hospitals Trust

🇬🇧

London, England, United Kingdom

Royal Marsden NHS Trust

🇬🇧

London, England, United Kingdom

Hammersmith Hospital

🇬🇧

London, England, United Kingdom

Middlesex Hospital- Meyerstein Institute

🇬🇧

London, England, United Kingdom

Scroll for more (12 remaining)
Royal United Hospital
🇬🇧Bath, England, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.